Psychological treatment for bipolar disorder

CBT for bipolar disorder is generally studied as part of ongoing clinical care. Findings about relapse prevention or depressive symptoms do not establish that an app treats mania or can replace medication management.

Literature checked · Review methods and limits

Clinical context

The CANMAT and ISBD summary places CBT among adjunctive psychological options for bipolar depression and maintenance, with psychoeducation and other interventions also having a role. Its treatment hierarchy considers more than efficacy alone (Keramatian et al., 2023). NICE similarly describes structured psychological interventions developed specifically for bipolar disorder, with attention to relapse, functioning, and individualized assessment (NICE, 2014a, section 1.7). This differs substantially from delivering generic positive-thinking exercises.

Sources: Keramatian et al., 2023; NICE, 2014a

What comparative research adds

A component network meta-analysis examined adjunctive psychotherapies across trials that included different populations and intervention packages (Miklowitz et al., 2021). Component associations in such a network do not randomize each component in isolation. An informative later trial compared structured CBT with a credible supportive, emotion-focused group treatment alongside psychiatric care. It did not support a simple claim that the structured programme was universally superior (Hautzinger & A2 BipoLife Consortium, 2024). Baseline imbalances and the distinction between unadjusted and adjusted analyses matter when interpreting that result.

Sources: Miklowitz et al., 2021; Hautzinger & A2 BipoLife Consortium, 2024

Limits and implications

Maintenance differs from acute treatment, and adult findings do not automatically apply to adolescents or to every bipolar I or bipolar II presentation. Mood tracking may be considered as a way to prepare a discussion with a clinician, but its benefits, possible overmonitoring, and responses to changing symptoms require direct evaluation. A future study would need a defined population, continuation of usual care, and meaningful follow-up of recurrence and functioning. These studies have not been claimed as research conducted by Umbrella Journal.

References

Links open the original papers or official sources. Access labels describe the material assessed for this review.

Clinical guidance · 2014

National Institute for Health and Care Excellence (2014a). Bipolar disorder: Assessment and management (CG185).

Access assessed: indexed abstract or official source excerpt

Publication · 2021

Miklowitz, D. J., Efthimiou, O., Furukawa, T. A., Scott, J., McLaren, R., Geddes, J. R., & Cipriani, A. (2021). Adjunctive psychotherapy for bipolar disorder: A systematic review and component network meta-analysis. JAMA Psychiatry, 78(2), 141–150. 10.1001/jamapsychiatry.2020.2993

Access assessed: Indexed publisher methods/results and PubMed metadata

Publication · 2024

Hautzinger, M., & A2 BipoLife Consortium (2024). Adjuvant psychotherapies to prevent relapse in bipolar disorder: A randomized clinical trial. JAMA Psychiatry, 81(9), 855–862. 10.1001/jamapsychiatry.2024.1310

Access assessed: Indexed publisher/PMC full-text methods and results passages

Explore the full source library

This selective evidence map is educational. It does not provide an individual diagnosis or treatment plan. Read the review methods, access limits, and clinical-review status.